Hans Joachim Lück

Evaluating the impact of Relative Total Dose Intensity (RTDI) on patients' short and long-term outcome in taxane- and anthracycline-based chemotherapy of metastatic breast cancer- a pooled analysis

Sibylle Loibl, Tomáš Skácel, Valentina Nekljudova et al. · BMC Cancer · 2011 · 122 citations · Full text

Medicine, Oncology, Pharmacology +17

Legumain expression as a prognostic factor in breast cancer patients

Jessica Gawenda, Frank Traub, Hans Joachim Lück et al. · Breast Cancer Research and Treatment · 2006 · 106 citations

Medicine, Cancer Biology, Oncology +11

Prognostic impact of Skp2 and p27 in human breast cancer

Frank Traub, Michael Mengel, Hans Joachim Lück et al. · Breast Cancer Research and Treatment · 2006 · 81 citations

Medicine, Molecular Biology, Oncology +12

Prognostic and Predictive Impact of the HER-2/neu Extracellular Domain (ECD) in the Serum of Patients Treated with Chemotherapy for Metastatic Breast Cancer

Volkmar Müller, Isabell Witzel, Hans Joachim Lück et al. · Breast Cancer Research and Treatment · 2004 · 69 citations

Medicine, Cancer Biology, Oncology +17

Prognostic and predictive impact of soluble epidermal growth factor receptor (sEGFR) protein in the serum of patients treated with chemotherapy for metastatic breast cancer.

Volkmar Müller, Isabell Witzel, Klaus Pantel et al. · PubMed · 2006 · 44 citations

Medicine, Cancer Biology, Oncology +15